Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...
Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have ...
Medical history has recently been made in a New York City hospital. This month, 21-year-old Sebastien Beauzile became the ...
FOX 5 New York on MSN4d
Sickle cell patient declared disease free after groundbreaking therapy on Long IslandA sickle cell gene therapy treatment has allowed a Long Island man to turn a chapter in his life, with doctors declaring him ...
Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have identified a potential new gene target that could be edited to treat sickle ...
Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...
It has been an amazing year for patients with sickle cell disease (SCD) with two new drug approvals in recent weeks, and hopes are also building that bluebird bio’s LentiGlobin gene therapy ...
You may have a high or low MCHC if you have sickle cell disease. The effects on your MCHC depend on what caused your sickle cell disease, Gallagher says. An MCHC is usually part of a complete ...
Scientists have discovered more than a dozen genes that regulate the production of fetal hemoglobin in people of African ...
Cell and gene therapies for degenerative eye diseases are still a long way off, but they have the potential to make a transformative difference to people’s lives. Vision impairment and loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback